Complement polymorphisms and cognitive dysfunction after carotid endarterectomy

Journal of Neurosurgery

Volumn 119, Issue 3, 2013, Pages 648-654

  Heyer, Eric J ^a   Kellner, Christopher P ^a   Malone, Hani R ^a   Bruce, Samuel S ^a   Mergeche, Joanna L ^a   Ward, Justin T ^a   Connolly Jr , E Sander ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Carotid endarterectomy; Cognitive dysfunction; Complement; Neuropsychometric; Single nucleotide polymorphism; Vascular disorders

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; COMPLEMENT COMPONENT C5; COMPLEMENT FACTOR H; MANNOSE BINDING LECTIN; MBL2 PROTEIN, HUMAN;

AGED; ARTICLE; CAROTID ENDARTERECTOMY; COGNITIVE DEFECT; COMPLEMENT COMPONENT C5 GENE; COMPLEMENT FACTOR H GENE; CONTROLLED STUDY; GENE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MANNOSE BINDING LECTIN 2 GENE; NEUROPSYCHOMETRY; PREDICTION; PRIORITY JOURNAL; PSYCHOMETRY; SINGLE NUCLEOTIDE POLYMORPHISM; BIOSYNTHESIS; COGNITION DISORDERS; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; GENETICS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROMOTER REGION; PROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COGNITION DISORDERS; COHORT STUDIES; COMPLEMENT C5; COMPLEMENT FACTOR H; ENDARTERECTOMY, CAROTID; FEMALE; HUMANS; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTOPERATIVE COMPLICATIONS; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES;

EID: 84884365734     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2013.4.JNS1368     Document Type: Article

References (36)

1. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I: Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125:279-284, 2001 (Pubitemid 33000466)
2. Cervera A, Planas AM, Justicia C, Urra X, Jensenius JC, Torres F, et al: Genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human stroke. PLoS ONE 5: e8433, 2010
3. Connolly ES Jr, Winfree CJ, Rampersad A, Sharma R, Mack WJ, Mocco J, et al: Serum S100B protein levels are correlated with subclinical neurocognitive declines after carotid endarterectomy. Neurosurgery 49:1076-1083, 2001 (Pubitemid 32995844)
4. Czermak BJ, Lentsch AB, Bless NM, Schmal H, Friedl HP, Ward PA: Role of complement in in vitro and in vivo lung inflammatory reactions. J Leukoc Biol 64:40-48, 1998 (Pubitemid 28304672)
5. Czerny M, Schuch P, Sodeck G, Bálassy C, Hoelzenbein T, Juraszek A, et al: Sustained cognitive benefit 5 years after carotid endarterectomy. J Vasc Surg 51:1139-1144, 2010
6. Elkind MS, Sacco RL, Macarthur RB, Peerschke E, Neils G, Andrews H, et al: High-dose lovastatin for acute ischemic stroke: results of the phase I dose escalation neuroprotection with statin therapy for acute recovery trial (NeuSTART). Cerebrovasc Dis 28:266-275, 2009
7. Gangnon RE, Lee KE, Klein BE, Iyengar SK, Sivakumaran TA, Klein R: Effect of the Y402H variant in the complement factor H gene on the incidence and progression of age-related macular degeneration: results from multistate models applied to the Beaver Dam Eye Study. Arch Ophthalmol 130:1169-1176, 2012
8. Garred P, Madsen HO, Hofmann B, Svejgaard A: Increased frequency of homozygosity of abnormal mannan-bindingprotein alleles in patients with suspected immunodeficiency. Lancet 346:941-943, 1995
9. Gaudet JG, Meyers PM, McKinsey JF, Lavine SD, Gray W, Mitchell E, et al: Incidence of moderate to severe cognitive dysfunction in patients treated with carotid artery stenting. Neurosurgery 65:325-330, 2009
10. Gaudet JG, Yocum GT, Lee SS, Granat A, Mikami M, Connolly ES Jr, et al: MMP-9 levels in elderly patients with cognitive dysfunction after carotid surgery. J Clin Neurosci 17: 436-440, 2010
11. Gigante PR, Kotchetkov IS, Kellner CP, Haque R, Ducruet AF, Hwang BY, et al: Polymorphisms in complement component 3 (C3F) and complement factor H (Y402H) increase the risk of postoperative neurocognitive dysfunction following carotid endarterectomy. J Neurol Neurosurg Psychiatry 82:247-253, 2011
12. Greisenegger S, Zehetmayer S, Bauer P, Endler G, Ferrari J, Lang W, et al: Polymorphisms in inflammatory genes and the risk of ischemic stroke and transient ischemic attack: results of a multilocus genotyping assay. Clin Chem 55:134-138, 2009
13. Heyer EJ, Adams DC, Solomon RA, Todd GJ, Quest DO, Mc- Mahon DJ, et al: Neuropsychometric changes in patients after carotid endarterectomy. Stroke 29:1110-1115, 1998 (Pubitemid 28265463)
14. Heyer EJ, Gold MI, Kirby EW, Zurica J, Mitchell E, Halazun HJ, et al: A study of cognitive dysfunction in patients having carotid endarterectomy performed with regional anesthesia. Anesth Analg 107:636-642, 2008
15. Heyer EJ, Mergeche JL, Bruce SS, Ward JT, Stern Y, Anastasian ZH, et al: Statins reduce neurologic injury in asymptomatic carotid endarterectomy patients. Stroke 44:1150-1152, 2013
16. Heyer EJ, Sharma R, Rampersad A, Winfree CJ, Mack WJ, Solomon RA, et al: A controlled prospective study of neuropsychological dysfunction following carotid endarterectomy. Arch Neurol 59:217-222, 2002 (Pubitemid 34240937)
17. Heyer EJ, Wilson DA, Sahlein DH, Mocco J, Williams SC, Sciacca R, et al: APOE-epsilon4 predisposes to cognitive dysfunction following uncomplicated carotid endarterectomy. Neurology 65:1759-1763, 2005
18. Ito A, Goto T, Maekawa K, Baba T, Mishima Y, Ushijima K: Postoperative neurological complications and risk factors for pre-existing silent brain infarction in elderly patients undergoing coronary artery bypass grafting. J Anesth 26:405-411, 2012
19. Kim IC, Hur SH, Park NH, Jun DH, Cho YK, Nam CW, et al: Incidence and predictors of silent embolic cerebral infarction following diagnostic coronary angiography. Int J Cardiol 148: 179-182, 2011
20. Mack WJ, Ducruet AF, Hickman ZL, Zurica J, Starke RM, Garrett MC, et al: Elevation of monocyte chemoattractant protein-1 in patients experiencing neurocognitive decline following carotid endarterectomy. Acta Neurochir (Wien) 150: 779-784, 2008
21. Madsen HO, Garred P, Thiel S, Kurtzhals JA, Lamm LU, Ryder LP, et al: Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 155:3013-3020, 1995
22. Madsen HO, Videm V, Svejgaard A, Svennevig JL, Garred P: Association of mannose-binding-lectin deficiency with severe atherosclerosis. Lancet 352:959-960, 1998 (Pubitemid 28427285)
23. Mazul-Sunko B, Hromatko I, Tadinac M, Sekulić A, Ivanec Z, Gvozdenović A, et al: Subclinical neurocognitive dysfunction after carotid endarterectomy-the impact of shunting. J Neurosurg Anesthesiol 22:195-201, 2010
24. Mocco J, Wilson DA, Komotar RJ, Sughrue ME, Coates K, Sacco RL, et al: Alterations in plasma complement levels after human ischemic stroke. Neurosurgery 59:28-33, 2006
25. Mocco J, Wilson DA, Komotar RJ, Zurica J, Mack WJ, Halazun HJ, et al: Predictors of neurocognitive decline after carotid endarterectomy. Neurosurgery 58:844-850, 2006
26. Moller JT, Cluitmans P, Rasmussen LS, Houx P, Rasmussen H, Canet J, et al: Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. Lancet 351:857-861, 1998 (Pubitemid 28121173)
27. Olsson S, Stokowska A, Holmegaard L, Jood K, Blomstrand C, Pekna M, et al: Genetic variation in complement component C3 shows association with ischaemic stroke. Eur J Neurol 18:1272-1274, 2011
28. Shaw PX, Zhang L, Zhang M, Du H, Zhao L, Lee C, et al: Complement factor H genotypes impact risk of age-related macular degeneration by interaction with oxidized phospholipids. Proc Natl Acad Sci U S A 109:13757-13762, 2012
29. Speidl WS, Exner M, Amighi J, Kastl SP, Zorn G, Maurer G, et al: Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis. Eur Heart J 26:2294-2299, 2005 (Pubitemid 41541394)
30. Stokowska A, Olsson S, Holmegaard L, Jood K, Blomstrand C, Jern C, et al: Plasma C3 and C3a levels in cryptogenic and large-vessel disease stroke: associations with outcome. Cerebrovasc Dis 32:114-122, 2011
31. Tapia-Perez JH, Rupa R, Zilke R, Gehring S, Voellger B, Schneider T: Continued statin therapy could improve the outcome after spontaneous intracerebral hemorrhage. Neurosurg Rev 36:279-287, 2013
32. Tedesco MM, Lee JT, Dalman RL, Lane B, Loh C, Haukoos JS, et al: Postprocedural microembolic events following carotid surgery and carotid angioplasty and stenting. J Vasc Surg 46:244-250, 2007 (Pubitemid 47422218)
33. Terrando N, Eriksson LI, Ryu JK, Yang T, Monaco C, Feldmann M, et al: Resolving postoperative neuroinflammation and cognitive decline. Ann Neurol 70:986-995, 2011
34. Van Dijk D, Jansen EW, Hijman R, Nierich AP, Diephuis JC, Moons KG, et al: Cognitive outcome after off-pump and onpump coronary artery bypass graft surgery: a randomized trial. JAMA 287:1405-1412, 2002 (Pubitemid 34250503)
35. Wasser K, Hildebrandt H, Gröschel S, Stojanovic T, Schmidt H, Gröschel K, et al: Age-dependent effects of carotid endarterectomy or stenting on cognitive performance. J Neurol 259:2309-2318, 2012
36. Yocum GT, Gaudet JG, Lee SS, Stern Y, Teverbaugh LA, Sciacca RR, et al: Inducible nitric oxide synthase promoter polymorphism affords protection against cognitive dysfunction after carotid endarterectomy. Stroke 40:1597-1603, 2009